Nykredit A/S’s BeOne Medicines Ltd ONC Stock Holding History

Nykredit A/S’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.2M	Buy	+4,225	New	+$1.24M	﹤0.01%	624

Other funds holding ONC

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Nykredit A/S's ONC Position: Q2 2026 in Review

Nykredit A/S opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 4,225 shares worth $1.2M. The stake represents ﹤0.01% of the portfolio and ranks #624 among its holdings.

221 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Nykredit A/S held 4,225 shares of BeOne Medicines Ltd worth $1.2M as of Q2 2026.
BeOne Medicines Ltd was a new Nykredit A/S position in Q2 2026.
BeOne Medicines Ltd made up ﹤0.01% of Nykredit A/S's portfolio in Q2 2026, its #624 holding.
221 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Nykredit A/S's 13F filing for Q2 2026, filed 13 Aug 2026.